The aim of this study is to compare the performance of two clinical decision rules to select patients with acute pulmonary embolism (PE) for outpatient treatment: the Hestia criteria and the simplified Pulmonary Embolism Severity Index (sPESI). From 2008 to 2010, 468 patients with PE were triaged with the Hestia criteria for outpatient treatment: 247 PE patients were treated at home and 221 were treated as inpatients. The outcome of interest was all-cause 30-day mortality. In a post-hoc fashion, the sPESI items were scored and patients were classified according to the sPESI in low and high risk groups. Of the 247 patients treated at home, 189 (77%) patients were classified as low risk according to the sPESI and 58 patients (23%) as high risk. In total, 11 patients died during the first month; two patients treated at home and nine patients treated in-hospital. None of the patients treated at home died of fatal PE. Both the Hestia criteria and sPESI selected >50% of patients as low risk, with good sensitivity and negative predictive values for 30-day mortality: 82% and 99% for the Hestia criteria and 91% and 100% for the sPESI, respectively. The Hestia criteria and the sPESI classified different patients eligible for outpatient treatment, with similar low risks for 30-day mortality. This study suggests that the Hestia criteria may identify a proportion of high risk sPESI patiennts who can be safely treated at home, this however requires further validation.

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH12-07-0466DOI Listing

Publication Analysis

Top Keywords

hestia criteria
24
patients treated
20
patients
14
pulmonary embolism
12
outpatient treatment
12
30-day mortality
12
high risk
12
patients acute
8
acute pulmonary
8
spesi
8

Similar Publications

Management of Acute Pulmonary Embolism: A Review.

J Assoc Physicians India

November 2024

Consultant and Head, Department of Cardiology, Safdarjung Hospital, Delhi, India.

Article Synopsis
  • Pulmonary embolism (PE) is a significant health concern in India, often missed or poorly managed, leading to increased risk of cardiovascular issues in hospitalized patients.
  • Current research and studies have improved understanding of PE diagnosis, assessment, and treatment strategies, emphasizing the need for risk stratification of patients based on mortality risk.
  • Recommended treatments include the use of anticoagulants and thrombolytics, with oral anticoagulants like warfarin and newer options (NOACs) being preferred for their ease of use and effectiveness at the time of diagnosis.
View Article and Find Full Text PDF

Risk assessment and management strategies in older patients with acute pulmonary embolism.

J Thromb Haemost

October 2024

Department of Internal Medicine-Section of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands. Electronic address: https://twitter.com/Erik_Klok_MD.

Background: Managing older patients with acute pulmonary embolism (PE) is challenging due to their underrepresentation in clinical trials, comorbidities, and increased complication risk.

Objectives: To evaluate risk assessment and management outcomes in older patients with PE focusing on home and reperfusion treatment.

Methods: A retrospective analysis was conducted on patients aged 70 years or older diagnosed with acute PE at an academic medical center (2015-2022).

View Article and Find Full Text PDF

JTH in Clinic: management of low-risk pulmonary embolism.

J Thromb Haemost

December 2024

Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA. Electronic address:

Article Synopsis
  • Pulmonary embolism (PE) is a serious cardiovascular condition commonly diagnosed in emergency settings, leading to high rates of illness and death.
  • After diagnosing PE, it's crucial to assess the risk of severe outcomes using tools like the PE Severity Index and European Society of Cardiology guidelines, which helps determine if patients should be hospitalized.
  • There's a growing trend to support early discharge with home-based anticoagulant therapy for low-risk patients, with criteria and guidelines in place, yet many such patients still end up admitted for inpatient care.
View Article and Find Full Text PDF

Pulmonary embolism (PE) presents with a spectrum of symptoms, ranging from asymptomatic cases to life-threatening events. Common symptoms include sudden dyspnea, chest pain, limb swelling, syncope, and hemoptysis. Clinical presentation varies based on thrombus burden, demographics, and time to presentation.

View Article and Find Full Text PDF

[Translation into French and republication of: "Home treatment for patients with cancer-associated venous thromboembolism"].

Rev Med Interne

April 2024

Université Paris Cité, Inserm UMR S1140, Innovations thérapeutiques en hémostase, Paris, France; Service de médecine interne, hôpital Louis-Mourier, AP-HP, Colombes, France; F-Crin INNOVTE network, Saint-Étienne, France.

Patients hospitalised with acute venous thromboembolism (VTE), and notably patients with pulmonary embolism, often remain in hospital for extended periods due to the perceived risk of complications. However, several studies have shown that home treatment of selected patients is feasible and safe, with a low incidence of adverse events. This may offer clear benefits for patients' quality of life, hospital planning and cost to the health service.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!